These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 3106799)
1. Different effects of 1-beta-D-arabinofuranosylcytosine and aphidicolin in S-phase cells--chromosome aberrations, cell-cycle delay and cytotoxicity. Moore RC; Randall C Mutat Res; 1987 May; 178(1):73-80. PubMed ID: 3106799 [TBL] [Abstract][Full Text] [Related]
2. Synergism of 1-beta-D-arabinofuranosylcytosine with itself and aphidicolin. Moore RC; Randell C Mutat Res; 1988 Jan; 207(1):37-40. PubMed ID: 3122036 [TBL] [Abstract][Full Text] [Related]
3. An investigation using inhibition of G2 repair of the molecular basis of lesions which result in chromosomal aberrations. Moore RC; Randell C; Bender MA Mutat Res; 1988 May; 199(1):229-33. PubMed ID: 3129653 [TBL] [Abstract][Full Text] [Related]
4. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function. Kufe DW; Munroe D; Herrick D; Egan E; Spriggs D Mol Pharmacol; 1984 Jul; 26(1):128-34. PubMed ID: 6431261 [TBL] [Abstract][Full Text] [Related]
5. In vivo effects of cytosine arabinoside on deoxyribonucleic acid replication in Chinese hamster ovary cells. 2. Cytosine arabinoside affects the rate of synthesis but not the pattern of labeling of an amplified chromosomal sequence at the onset of the S period. Heintz NH; Hamlin JL Biochemistry; 1983 Jul; 22(15):3557-62. PubMed ID: 6615784 [TBL] [Abstract][Full Text] [Related]
6. DNA strand breaks caused by inhibitors of DNA synthesis: 1-beta-D-arabinofuranosylcytosine and aphidicolin. Fram RJ; Kufe DW Cancer Res; 1982 Oct; 42(10):4050-3. PubMed ID: 6809309 [TBL] [Abstract][Full Text] [Related]
7. Effects of repair inhibition in the G1 phase of clastogen-treated human lymphocytes on the frequencies of chromosome-type and chromatid-type aberrations and sister-chromatid exchanges. Kishi K Mutat Res; 1987 Jan; 176(1):105-16. PubMed ID: 3796655 [TBL] [Abstract][Full Text] [Related]
8. Potentiation of ara-C induced cytotoxicity by hydroxyurea in LoVo colon carcinoma cells. Robichaud NJ; Fram RJ Biochem Pharmacol; 1987 May; 36(10):1673-7. PubMed ID: 3109427 [TBL] [Abstract][Full Text] [Related]
9. The synergistic effect of aphidicolin on the yield of X-ray-induced chromosome aberrations throughout the cell cycle in JU56 cells. Moore RC; Bender MA Radiat Res; 1987 Jun; 110(3):385-95. PubMed ID: 3108953 [TBL] [Abstract][Full Text] [Related]
10. Effects of 1-beta-D-arabinofuranosylcytosine on chromosomes, depending upon the cell cycle stage at the time of exposure. Moore RC Mutat Res; 1981 Oct; 83(3):361-74. PubMed ID: 7329428 [TBL] [Abstract][Full Text] [Related]
11. Dose relationships between different effects of aphidicolin in JU56 cells. Moore RC; Randell C; Bender MA Mutat Res; 1986 Apr; 160(2):103-9. PubMed ID: 3081795 [TBL] [Abstract][Full Text] [Related]
12. Bromodeoxyuridine enhancement of 1-beta-D-arabinofuranosylcytosine metabolic activation and toxicity in HL-60 leukemic cells. Ross DD; Joneckis CC; Song TH; Wu RK Cancer Res; 1988 Feb; 48(3):517-21. PubMed ID: 3335018 [TBL] [Abstract][Full Text] [Related]
13. Cellular and clinical pharmacology of low-dose ara-C. Kufe DW; Griffin JD; Spriggs DR Semin Oncol; 1985 Jun; 12(2 Suppl 3):200-7. PubMed ID: 3925558 [TBL] [Abstract][Full Text] [Related]
14. Effect of tetrahydrouridine on the action of 1-beta-D-arabinofuranosylcytosine in synchronized cultures of normal rat kidney cells. Wan CW; Mak TW Cancer Res; 1979 Oct; 39(10):3981-5. PubMed ID: 476637 [TBL] [Abstract][Full Text] [Related]
15. Evidence for a new mechanism of cytotoxicity of 1-beta-D arabinofuranosylcytosine. Woodcock DM; Fox RM; Cooper IA Cancer Res; 1979 Apr; 39(4):1418-24. PubMed ID: 421225 [TBL] [Abstract][Full Text] [Related]
16. Sodium fluoride-induced chromosome aberrations in different stages of the cell cycle: a proposed mechanism. Aardema MJ; Gibson DP; LeBoeuf RA Mutat Res; 1989 Jun; 223(2):191-203. PubMed ID: 2500593 [TBL] [Abstract][Full Text] [Related]
17. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60. Grant S; Bhalla K; Rauscher F; Cadman E Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943 [TBL] [Abstract][Full Text] [Related]
18. Schedule-dependent enhancement of 1-beta-D-arabinofuranosylcytosine incorporation into HL-60 DNA by deoxyguanosine. Ross DD; Akman SA; Joneckis CC; Yang E; Bachur NR Cancer Res; 1984 Apr; 44(4):1530-5. PubMed ID: 6584206 [TBL] [Abstract][Full Text] [Related]
19. Cell cycle related change of Ara-C transport in HL-60 cells after differentiation induction. Takimoto T; Kubota M; Tsuruta S; Kitoh T; Tanizawa A; Akiyama Y; Mikawa H FEBS Lett; 1989 Apr; 247(2):173-6. PubMed ID: 2497027 [TBL] [Abstract][Full Text] [Related]
20. Cytosine arabinoside is a potent clastogen and does not affect the repair of X-ray-induced chromosome fragments in unstimulated human lymphocytes. Pantelias GE; Wolff S Mutat Res; 1985 Aug; 151(1):65-72. PubMed ID: 4022039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]